Early Complete Remitters After Electroconvulsive Therapy: Profile and Prognosis

The Journal of ECT
Harm-Pieter SpaansPascal Sienaert

Abstract

To investigate the prevalence, characteristics, and prognosis of depressive patients who show early complete remission after right unilateral (ultra)brief pulse electroconvulsive therapy (ECT). Early complete remitters (ECRs) were those patients who were rated 1 on the Clinical Global Impression Scale (maximum score, 7) within 4 ECT sessions and achieved remission (Montgomery Åsberg Depression Rating Scale score, <10). The ECRs were compared with late complete remitters (LCRs), which fulfilled the same criteria after 9 to 12 ECT sessions and with the nonremitters/nonresponders (NRs). Of the 87 patients who completed the index treatment phase, 50 (57.5%) achieved remission. Of these remitters, 12 (14%) were ECRs and 9 (10%) were LCRs. The ECRs were characterized by a higher mean age (71.0 vs 53.9 years; P = 0.008), a shorter current depressive episode (mean, 5.8 vs 15.4 months; P = 0.042), and more psychotic features (75% vs 22%; P = 0.030) and were treated more often with brief pulse ECT (P = 0.030) compared with the LCRs. Although not significant, cognitive performances of ECRs were lower than that of LCRs at baseline with a large effect size: Autobiographical Memory Interview (P = 0.099; d = 0.83), Amsterdam Media Questionnai...Continue Reading

References

Apr 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·S A Montgomery, M Asberg
May 1, 1976·Archives of General Psychiatry·R Abrams, M A Taylor
Jul 21, 1970·Biochimica Et Biophysica Acta·N Nagata, H Rasmussen
Jan 1, 1984·The American Journal of Psychiatry·R Keisling
Apr 1, 1983·The American Journal of Psychiatry·R AbramsG Almy
Mar 1, 1981·The British Journal of Psychiatry : the Journal of Mental Science·C Dé MontignyJ P Deschenes
Nov 1, 1995·Psychological Medicine·E S PaykelA Barocka
Aug 1, 1996·The American Journal of Psychiatry·J PrudicH A Sackeim
Jul 1, 1996·The British Journal of Psychiatry : the Journal of Mental Science·I HickieH Brodaty
May 3, 2001·Bipolar Disorders·J J DalyH A Sackeim
Jan 18, 2003·Sleep Medicine Reviews·Henner Giedke, Frank Schwärzler
Mar 7, 2003·The Journal of ECT·Stephanie G Thomas, Charles H Kellner
Sep 9, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Warren D TaylorK Ranga Rama Krishnan
Jun 7, 2005·Journal of Affective Disorders·Iris M de VreedeIrene M van Vliet
Jul 15, 2005·The Journal of Clinical Psychiatry·King Han KhoBen A Blansjaar
Aug 10, 2005·The Journal of Clinical Psychiatry·Alexandre Y DombrovskiHarold A Sackeim
Dec 27, 2005·Journal of Affective Disorders·Esther M PluijmsWalter W van den Broek
Jun 24, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·A John RushUNKNOWN ACNP Task Force
Jul 11, 2006·Journal of Clinical and Experimental Neuropsychology·M MeeterJ L Mulder
Feb 7, 2007·Acta Psychiatrica Scandinavica. Supplementum·G Parker
Mar 3, 2010·The British Journal of Psychiatry : the Journal of Mental Science·Charles H KellnerGeorgios Petrides
Jul 3, 2010·The American Journal of Psychiatry·Gordon ParkerConrad Swartz
Sep 2, 2010·The Journal of ECT·Angel V PeterchevSarah H Lisanby
Sep 12, 2012·The International Journal of Neuropsychopharmacology·Colleen K LooDusan Hadzi-Pavlovic
Jan 11, 2013·The Journal of ECT·Joan PrudicHarold A Sackeim
Jun 25, 2013·Journal of Affective Disorders·Harm-Pieter SpaansMax L Stek
Jun 22, 2014·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Didi RhebergenMax Stek
Dec 30, 2014·Frontiers in Psychiatry·Pascal SienaertGábor Gazdag

❮ Previous
Next ❯

Citations

Aug 11, 2019·Acta Psychiatrica Scandinavica·P Sienaert, C H Kellner
Jun 14, 2019·The Journal of ECT·Linda van DiermenDidier Schrijvers
Apr 21, 2020·Acta Psychiatrica Scandinavica·T K Birkenhager, L van Diermen
Jul 3, 2020·Indian Journal of Psychological Medicine·Jagadisha ThirthalliGirish Kunigiri
Nov 26, 2019·The Journal of ECT·Linda van DiermenDidier Schrijvers
Aug 4, 2020·Journal of Affective Disorders·Margot J WagenmakersAnnemieke Dols

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.